XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock [Member]
Total
Balance at the beginning of period at Jun. 30, 2021 $ 811 $ 519,826 $ 2,005,105 $ (7,365) $ (1,217,307) $ 1,301,070
Balance at the beginning of period (in shares) at Jun. 30, 2021 81,099       31,846  
Net income (loss)     (40,151)     (40,151)
Other comprehensive loss, net of tax       36   36
Reclassification adjustment for loss on interest rate swap       6,695   6,695
Stock-based compensation   14,287       14,287
Net activity from stock-based compensation awards $ 6 8,194     $ (2,518) 5,682
Net activity from stock-based compensation awards (in shares) 606       69  
Proceeds from stock issued under Colleague Stock Purchase Plan   (11)     $ 282 271
Proceeds from stock issued under Colleague Stock Purchase Plan (in shares)         (7)  
Balance at the end of period at Dec. 31, 2021 $ 817 542,296 1,964,954 (634) $ (1,219,543) $ 1,287,890
Balance at the end of period (in shares) at Dec. 31, 2021 81,705       31,908 49,797
Balance at the beginning of period at Sep. 30, 2021 $ 817 537,402 1,947,101 (740) $ (1,219,399) $ 1,265,181
Balance at the beginning of period (in shares) at Sep. 30, 2021 81,656       31,903  
Net income (loss)     17,853     17,853
Other comprehensive loss, net of tax       106   106
Reclassification adjustment for loss on interest rate swap           0
Stock-based compensation   4,381       4,381
Net activity from stock-based compensation awards   514     $ (290) 224
Net activity from stock-based compensation awards (in shares) 49       9  
Proceeds from stock issued under Colleague Stock Purchase Plan   (1)     $ 146 145
Proceeds from stock issued under Colleague Stock Purchase Plan (in shares)         (4)  
Balance at the end of period at Dec. 31, 2021 $ 817 542,296 1,964,954 (634) $ (1,219,543) $ 1,287,890
Balance at the end of period (in shares) at Dec. 31, 2021 81,705       31,908 49,797
Balance at the beginning of period at Jun. 30, 2022 $ 818 521,848 2,322,810 (960) $ (1,339,449) $ 1,505,067
Balance at the beginning of period (in shares) at Jun. 30, 2022 81,796       36,619 45,177
Net income (loss)     26,336     $ 26,336
Other comprehensive loss, net of tax       (1,267)   (1,267)
Reclassification adjustment for loss on interest rate swap           0
Stock-based compensation   8,113       8,113
Net activity from stock-based compensation awards $ 4 1,418     $ (4,108) (2,686)
Net activity from stock-based compensation awards (in shares) 360       103  
Proceeds from stock issued under Colleague Stock Purchase Plan   (3)     $ 324 321
Proceeds from stock issued under Colleague Stock Purchase Plan (in shares)         (9)  
Settlement of equity forward contract   30,000     $ (43,162) (13,162)
Balance at the end of period at Dec. 31, 2022 $ 822 561,376 2,349,146 (2,227) $ (1,386,395) $ 1,522,722
Balance at the end of period (in shares) at Dec. 31, 2022 82,156       36,713 45,443
Balance at the beginning of period at Sep. 30, 2022 $ 821 529,229 2,325,002 (2,227) $ (1,342,786) $ 1,510,039
Balance at the beginning of period (in shares) at Sep. 30, 2022 82,099       36,703  
Net income (loss)     24,144     24,144
Reclassification adjustment for loss on interest rate swap           0
Stock-based compensation   1,968       1,968
Net activity from stock-based compensation awards $ 1 180     $ (622) (441)
Net activity from stock-based compensation awards (in shares) 57       15  
Proceeds from stock issued under Colleague Stock Purchase Plan   (1)     $ 175 174
Proceeds from stock issued under Colleague Stock Purchase Plan (in shares)         (5)  
Settlement of equity forward contract   30,000     $ (43,162) (13,162)
Balance at the end of period at Dec. 31, 2022 $ 822 $ 561,376 $ 2,349,146 $ (2,227) $ (1,386,395) $ 1,522,722
Balance at the end of period (in shares) at Dec. 31, 2022 82,156       36,713 45,443